• Elanco Animal Health Inc ELAN.N reported quarterly adjusted earnings of 14 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 8 cents. The mean expectation of twelve analysts for the quarter was for earnings of 15 cents per share. Wall Street expected results to range from 13 cents to 17 cents per share.

• Revenue fell 1.4% to $1.02 billion from a year ago; analysts expected $1.01 billion.

• Elanco Animal Health Inc's reported EPS for the quarter was a loss of 2 cents​.

• The company reported a quarterly loss of $8 million.

• Elanco Animal Health Inc shares had fallen by 8.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 3% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 7 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Elanco Animal Health Inc is $18.00

This summary was machine generated from LSEG data February 25 at 02:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)